Prevalence of Antiphospholipid Antibodies and Association With Incident Cardiovascular Events

IMPORTANCE: The prevalence of antiphospholipid antibodies (aPL) and their association with future atherosclerotic cardiovascular disease (ASCVD) risk has yet to be thoroughly investigated. OBJECTIVE: To determine the association between measurements of aPL at a single time point and ASCVD risk in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Yu, Navaz, Sherwin, Liang, Wenying, Li, Chun, Ayers, Colby R., Rysenga, Christine E., Harbaugh, Alyssa, Norman, Gary L., Solow, E. Blair, Bermas, Bonnie, Akinmolayemi, Oludamilola, Rohatgi, Anand, Karp, David R., Knight, Jason S., de Lemos, James A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074226/
https://www.ncbi.nlm.nih.gov/pubmed/37014642
http://dx.doi.org/10.1001/jamanetworkopen.2023.6530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074226/
https://www.ncbi.nlm.nih.gov/pubmed/37014642
http://dx.doi.org/10.1001/jamanetworkopen.2023.6530

Ejemplares similares